Maps tumor DNA variants to reveal what is driving a cancer and which changes can be targeted.
Consented intake · your records travel with you · nothing moves without your sign-off
Sequencing.com provides DNA sequencing that maps and analyzes tumor tissue for DNA variants. The aim is to uncover the genetic coding driving a patient's cancer, especially variants of interest that can be targeted for treatment. Whole exome raw data is most useful when a personalized vaccine is being considered, making this a foundational step for many treatment decisions.
Prefer the source? Sequencing.com's own site has more.
The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how Sequencing.com handles billing.
We don't have confirmed insurance details for Sequencing.com yet. Start a coverage check with your plan, or contact the provider directly.
Answers grounded in Sequencing.com's details here. Educational only; your oncologist directs treatment.
Ask OpenCancer · answers grounded in this storefront
Other providers in similar categories.
Gather distinctive biomarkers that can guide treatment and monitor disease progression
FoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.
Tempus xT is a comprehensive genomic profiling test combining DNA and RNA sequencing to identify actionable mutations.
Matches your tumor's biomarkers to the therapies most likely to work for you — mapping your molecular profile to targeted and approved options.
This page is general information. Upload your records for analysis specific to YOUR diagnosis.